Opiant Pharmaceuticals Inc (OPNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,195 | -11,658 | -10,740 | -9,344 | N/A |
| Depreciation Amortization | 3 | 2 | 2 | 1 | N/A |
| Accounts receivable | 7,207 | 7,585 | 8,727 | 10,048 | N/A |
| Accounts payable and accrued liabilities | -1,924 | -2,497 | -1,685 | 221 | N/A |
| Other Working Capital | 14,127 | 5,877 | 7,493 | 9,934 | N/A |
| Other Operating Activity | 1,259 | 386 | -3,119 | -8,660 | 0 |
| Operating Cash Flow | $-523 | $-305 | $678 | $2,200 | $N/A |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 17,187 | 17,187 | 2,556 | 1,030 | N/A |
| Other Financing Activity | -166 | -173 | -105 | 0 | 0 |
| Financing Cash Flow | $17,021 | $17,014 | $2,451 | $1,030 | $N/A |
| Beginning Cash Position | 8,116 | 8,116 | 8,116 | 8,116 | N/A |
| End Cash Position | 24,614 | 24,825 | 11,245 | 11,346 | N/A |
| Net Cash Flow | $16,498 | $16,709 | $3,129 | $3,230 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -523 | -305 | 678 | 2,200 | N/A |
| Free Cash Flow | -523 | -305 | 678 | 2,200 | 0 |